Page last updated: 2024-08-23

paclitaxel and Lymphoma, Follicular

paclitaxel has been researched along with Lymphoma, Follicular in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kimura, D; Masuda, T; Nakashima, Y; Narazaki, T; Ogawa, Y; Ohshima, K; Shiratsuchi, M; Takamatsu, A; Tsuda, M; Tsukamoto, Y1
Allman, R; Errington, RJ; Smith, PJ1
Cabanillas, F; Hagemeister, FB; McLaughlin, P; Pro, B; Rodriguez, MA; Romaguera, J; Tiongson, LP; Younes, A1
Andreeff, M; Cabanillas, F; Consoli, U; Huh, Y; McLaughlin, P; Rodriguez, A; Sarris, A; Starry, S; Younes, A1
Bassan, R; Di Gaetano, N; Erba, E; Golay, J; Introna, M; Rambaldi, A; Xiao, Y1

Trials

2 trial(s) available for paclitaxel and Lymphoma, Follicular

ArticleYear
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paclitaxel; Survival Rate; Treatment Outcome; Vidarabine

2006
A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results.
    Blood, 1996, Mar-01, Volume: 87, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow; Combined Modality Therapy; Female; Growth Inhibitors; Hematopoiesis; Humans; Immunologic Factors; Interleukin-3; Lymphoma, Follicular; Male; Middle Aged; Neoplastic Stem Cells; Neutrophils; Paclitaxel; Pilot Projects; Treatment Outcome

1996

Other Studies

3 other study(ies) available for paclitaxel and Lymphoma, Follicular

ArticleYear
Transformation of follicular lymphoma to double-hit lymphoma during adjuvant chemotherapy for concurrent ovarian carcinoma.
    International journal of hematology, 2019, Volume: 110, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Female; Humans; Lymphoma, Follicular; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel

2019
Delayed expression of apoptosis in human lymphoma cells undergoing low-dose taxol-induced mitotic stress.
    British journal of cancer, 2003, May-19, Volume: 88, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphoma, B-Cell; Lymphoma, Follicular; Mitosis; Paclitaxel; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2003
Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone.
    British journal of haematology, 2001, Volume: 114, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Blotting, Northern; Cisplatin; Complement System Proteins; Cytotoxicity Tests, Immunologic; Doxorubicin; Drug Synergism; Fluorescent Antibody Technique; Humans; Idarubicin; In Situ Nick-End Labeling; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Paclitaxel; Rituximab; Tumor Cells, Cultured; Vidarabine

2001